Mag­no­lia bags a $20M CPRIT grant to back tri­al work on new drug; Evotec lines up a new part­ner on rare ge­net­ic ...

7 years ago
News Briefing

Har­bour Bio­Med fol­lows can­cer drug deals with a hefty $85M Se­ries B backed by Sin­ga­pore's GIC

7 years ago
Financing
China

Drug prices in ads: Sen­ate pass­es amend­ment

7 years ago
Pharma

Jump­ing ahead of As­traZeneca, Ab­b­Vie and J&J get a green light to mar­ket Im­bru­vi­ca/Rit­ux­an com­bo for rare lym­phoma

7 years ago
Pharma

No­var­tis wins a key OK for Kym­ri­ah, but con­tin­u­ing man­u­fac­tur­ing woes hob­ble roll­out — ri­val Gilead CAR-T breaks ...

7 years ago
Pharma

Es­pe­ri­on of­fers an­oth­er up­beat cut of piv­otal cho­les­terol da­ta for their com­bo, bumps back read­out for key safe­ty ...

7 years ago
R&D

Pfiz­er im­press­es car­dio crowd with mor­tal­i­ty and hos­pi­tal­iza­tion rates for tafamidis in AT­TR-CM -- but Al­ny­lam ...

7 years ago
R&D

Y-mAbs’ sto­ry comes in­to the light: a ship­ping ty­coon, the MSK re­searcher, a par­tial hold and a $92M IPO gam­ble

7 years ago
Financing

J&J, Bay­er fail at their sec­ond big at­tempt to spot­light a safe ben­e­fit for clot-buster Xarel­to in VTE

7 years ago
R&D

Chi­na Bi­o­log­ic re­jects $3.9B buy­out bid from ex-CEO; Leo Phar­ma bags atopic der­mati­tis drug for $17M up­front

7 years ago
News Briefing

E-Scape Bio in­stalls per­ma­nent CEO Julie Anne Smith; Fa­ther pass­es reins to son at Al­le­gro Oph­thalmics

7 years ago
Peer Review

Zai Lab bombs Phase IIa tri­al in atopic der­mati­tis, junks the pro­gram to shift re­sources to the pipeline

7 years ago
R&D

Out: NIH bud­get cuts. In: Alzheimer’s R&D as law­mak­ers boost pro­posed ’19 spend­ing to $2.3B

7 years ago
R&D

Shire wins a block­buster OK for pipeline star lanadelum­ab, boost­ing Take­da’s $62B takeover deal

7 years ago
Pharma

New­ly part­nered with blue­bird, Grit­stone seeks $80M IPO in fi­nal dash for clin­ic

7 years ago
Financing

Need a place­bo con­trol group for your next can­cer drug study? On­ly in cer­tain cir­cum­stances, says FDA

7 years ago
Pharma

Sang­amo re­searcher charged with in­sid­er trad­ing in lat­est round of SEC ac­cu­sa­tions lev­eled at a biotech ex­ec

7 years ago
People
Pharma

A new av­enue for di­et pill mak­ers? UC San Diego re­searchers un­cov­er root of lep­tin re­sis­tance

7 years ago
Discovery

New co-CEO named at WuXi; Bris­tol-My­ers gets pri­or­i­ty re­view for myelo­ma com­bo fea­tur­ing Em­plic­i­ti

7 years ago
News Briefing

Once laud­ed for its clin­i­cal suc­cess, Roche casts off car­dio pro­gram in­clacum­ab for a mere $2M to Glob­al Blood ...

7 years ago
Pharma

TCR deal fren­zy con­tin­ues as blue­bird antes up $30M for new Grit­stone al­liance

7 years ago
Pharma

Japan­ese bil­lion­aire Hi­roshi Mik­i­tani bankrolls As­pyr­i­an with a $150M mega-round, back­ing a glob­al roll­out plan for ...

7 years ago
Financing

Hit by sur­prise set­back, As­traZeneca scram­bles to ex­plain why its two-in-one COPD in­haler was beat­en by GSK ri­val

7 years ago
R&D

New­born bio­bet­ter, biosim­i­lar mak­er Mabpharm pitch­es the lat­est biotech IPO in Hong Kong

7 years ago
Financing
China
First page Previous page 1015101610171018101910201021 Next page Last page
A service from the Financial Times